12:00 AM
 | 
Oct 11, 1999
 |  BC Week In Review  |  Company News  |  Deals

Corixa, Ribi ImmunoChem deal

CRXA completed its acquisition of RIBI for $58.5 million, consisting of $48 million worth of CRXA stock in exchange for...

Read the full 78 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >